{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:41:09Z","timestamp":1778193669104,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clml.2024.06.010","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T02:31:56Z","timestamp":1720233116000},"page":"804-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple Myeloma"],"prefix":"10.1016","volume":"24","author":[{"given":"Mingee","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Bilal","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-8907","authenticated-orcid":false,"given":"Bicky","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binod","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clml.2024.06.010_bib0001","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"NCCN Guidelines Index Table of Contents Discussion","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.clml.2024.06.010_bib0002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1086\/514626","article-title":"Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review","volume":"27","author":"Hughes","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.clml.2024.06.010_bib0003","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/cncr.25904","article-title":"Dapsone-induced methemoglobinemia: a dose-related occurrence?","volume":"117","author":"Esbenshade","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clml.2024.06.010_bib0004","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/pathogens10020237","article-title":"Pneumocystis jirovecii pneumonia prophylaxis for cancer patients during chemotherapy","volume":"10","author":"Takeuchi","year":"2021","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/j.clml.2024.06.010_bib0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bbmt.2005.04.011","article-title":"Toxicity and efficacy of daily dapsone as pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study","volume":"11","author":"Sangiolo","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.clml.2024.06.010_bib0006","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pbc.20164","article-title":"Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels","volume":"44","author":"Williams","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.clml.2024.06.010_bib0007","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.jvca.2013.02.005","article-title":"Methemoglobinemia: a review and recommendations for management","volume":"28","author":"Cortazzo","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1016\/j.clml.2024.06.010_bib0008","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbmt.2005.10.008","article-title":"Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation","volume":"12","author":"Dunford","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.clml.2024.06.010_bib0009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-009-9813-8","article-title":"Dapsone induced methemoglobinemia in a patient with glioblastoma","volume":"94","author":"Walker","year":"2009","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.clml.2024.06.010_bib0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/bmt.2011.83","article-title":"High prevalence of dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency","volume":"47","author":"Olteanu","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2024.06.010_bib0011","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2016.01.029","article-title":"Oxidative stress and proteasome inhibitors in multiple myeloma","volume":"105","author":"Lipchick","year":"2016","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.clml.2024.06.010_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ccm.0000424641.07134.30","article-title":"423: acquired methemoglobinemia in cancer patients admitted to the ICU: causes and outcomes","volume":"40","author":"Rajendram","year":"2012","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.clml.2024.06.010_bib0013","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/jpon.2007.26876","article-title":"Dapsone-induced methemoglobinemia in pediatric oncology patients: case examples","volume":"18","author":"Mandrell","year":"2001","journal-title":"J Pediatr Oncol Nurs"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:09:50Z","timestamp":1729595390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024002441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2152265024002441"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.06.010","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}